These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25941099)

  • 21. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.
    Brunner SM; Weber F; Werner JM; Agha A; Farkas SA; Schlitt HJ; Hornung M
    BMC Surg; 2015 Apr; 15():49. PubMed ID: 25928025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New prognostic and predictive markers for breast cancer].
    Wachter DL
    Pathologe; 2016 Nov; 37(Suppl 2):217-222. PubMed ID: 27638528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.
    Chatani PD; Agarwal SK; Sadowski SM
    Front Endocrinol (Lausanne); 2020; 11():575620. PubMed ID: 33537001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
    Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
    Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances.
    Guilmette JM; Nosé V
    Adv Anat Pathol; 2019 Jan; 26(1):13-30. PubMed ID: 29912000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine Neoplasms of the Pancreas: Diagnostic Challenges and Practical Approach.
    Alipour Z; Sweeney JR; Zhang Q; Yang Z
    Adv Anat Pathol; 2023 Jan; 30(1):58-68. PubMed ID: 36136369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression.
    Martin DR; LaBauve E; Pomo JM; Chiu VK; Hanson JA; Gullapalli RR
    Pancreas; 2018 Apr; 47(4):502-510. PubMed ID: 29521944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic Classification of Neuroendocrine Neoplasms.
    Klimstra DS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):1-19. PubMed ID: 26614366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic endocrine tumors.
    Asa SL
    Mod Pathol; 2011 Apr; 24 Suppl 2():S66-77. PubMed ID: 21455203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of Pancreatic Neuroendocrine Tumors.
    Mohindroo C; McAllister F; De Jesus-Acosta A
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):1033-1051. PubMed ID: 36154786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
    Scarpa A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological and immunohistochemical profile of pancreatic neuroendocrine neoplasms.
    Simtniece Z; Vanags A; Strumfa I; Sperga M; Vasko E; Prieditis P; Trapencieris P; Gardovskis J
    Pol J Pathol; 2015 Jun; 66(2):176-94. PubMed ID: 26247532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroendocrine tumors of the kidneys].
    Moch H
    Pathologe; 2015 May; 36(3):278-82. PubMed ID: 25898936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?
    Uccella S
    Endocr Pathol; 2024 Jun; 35(2):91-106. PubMed ID: 38470548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.
    Inzani F; Petrone G; Rindi G
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):463-470. PubMed ID: 30098710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of spontaneous pancreatic neuroendocrine tumors.
    Yu R
    Mol Cell Endocrinol; 2016 Feb; 421():60-7. PubMed ID: 26261055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology of NET: Current concepts and new developments.
    Schmitt AM; Blank A; Marinoni I; Komminoth P; Perren A
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):33-43. PubMed ID: 26971842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.
    Lee L; Ito T; Jensen RT
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1029-1050. PubMed ID: 31738624
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathology of neuroendocrine neoplasms].
    Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G
    Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histo- and molecular pathology in gastroenteropancreatic neuroendocrine neoplasms].
    Kellers F; Schulte DM; Jesinghaus M; Konukiewitz B
    Dtsch Med Wochenschr; 2024 Aug; 149(15):887-893. PubMed ID: 39013409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.